Thomas Lechmere

The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study

Satveer K. Mahil, Katie Bechman, Antony Raharja et al. · The Lancet Rheumatology · 2021 · 176 citations · Full text

Medicine, Dermatology, Immunology +17

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Liane Dupont, Luke B. Snell, Carl Graham et al. · Nature Microbiology · 2021 · 116 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia

Patrick Harrington, Katie J. Doores, Deepti Radia et al. · British Journal of Haematology · 2021 · 64 citations · Full text

Medicine, Immunology, Oncology +17

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study

Satveer K. Mahil, Katie Bechman, Antony Raharja et al. · QUT ePrints (Queensland University of Technology) · 2022 · 53 citations

Life Sciences, Immunology, Pharmacology +16

Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

Patrick Harrington, Hugues de Lavallade, Katie J. Doores et al. · Leukemia · 2021 · 44 citations · Full text

Medicine, Hematology, Immunology +11